Analgesics in Argentina
Acetaminophen, particularly paediatric acetaminophen, will see strong current retail value growth in 2020, driven by Genomma Laboratories’ strong investment. The impact of COVID-19, along with the Dengue outbreak which, until May 2020, had a higher infection rate than COVID-19, has driven demand for analgesics in Argentina in 2020, as consumers seek to relieve symptoms of these diseases.
Get Free Sample Report : https://www.wiseguyreports.com/sample-request/3797933-analgesics-in-argentina
Euromonitor International’s Analgesics in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Table of Contents
Analgesics in Argentina
List OF CONTENTS AND TABLES
KEY DATA FINDINGS
COVID-19 drives strong growth in analgesics in 2020, as consumers seek to relieve virus symptoms
Genomma Laboratories performs strongly in 2020 with a wide portfolio of products
Leader Bayer Argentina helps drive sales through downsizing its aspirin packs
RECOVERY AND OPPORTUNITIES
Topical analgesics/anaesthetic will continue to be slightly more dynamic than systemic analgesics into forecast period
Adult acetaminophen will benefit from Genomma’s investments
Players moving towards stronger doses of ibuprofen, aspirin and paracetamol
Table 1 Sales of Analgesics by Category: Value 2015-2020
Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
COVID-19 impact on consumer health
COVID-19 country impact
What next for consumer health?
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 8 Life Expectancy at Birth 2015-2020
Table 9 Sales of Consumer Health by Category: Value 2015-2020
Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 13 Distribution of Consumer Health by Format: % Value 2015-2020
Table 14 Distribution of Consumer Health by Format and Category: % Value 2020
Table 15 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Summary 1 OTC: Switches 2019-2020
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
Summary 2 Research Sources
Summary 1 Research Sources
+44 203 500 2763
+1 62 825 80070